Passage Bio's IPO tops out at $248.4M after options exercised
March 11, 2020 at 11:35 AM EDT
The IPO set a record for the amount raised by a Philadelphia-area cell or gene therapy company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|